Abstract
The presence of hyopmagnesemia related to the secondary hyperaldosteronism of cirrhosis was confirmed in 15 children and adolescents. Normomagnesemic levels returned in 6 of 7 patients treated with an aldosterone antagonist. The implications of such a response to therapy and of the progression from normal to low serum magnesium levels are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 453-455 |
Number of pages | 3 |
Journal | The Journal of Pediatrics |
Volume | 76 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1970 |
Externally published | Yes |
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health